Most of us will know someone, or maybe even several people, with a nut allergy. This particular allergy has become increasingly common over the last few decades, which is why some of the developments on the DBV Technologies website are to be welcomed with open arms.
Huge strides are being made in the field of epicutaneous immunotherapy. Click here if you’d like to discover more about the Paris firm that’s leading the charge. The growth in the incidence of allergies has been noticeable in recent years. Well-known allergies cover everything from nuts and eggs to shellfish.
French company DBV-Technologies is currently developing a number of allergy treatments that could radically improve the lives of millions of people around the globe. Allergies now affect a large proportion of the population of the western world. Symptoms can range from the merely uncomfortable – rashes, streaming eyes and noses,…
Most of us don’t think particularly hard about what we eat – but for some people, eating the wrong foods can be a matter of life and death. Over a hundred people die from eating peanuts in the US every year due to severe allergic reactions, also known as anaphylactic…
